2026, Number 2
<< Back
Aten Fam 2026; 33 (2)
Clinical and Social Challenges in Women Under 40 Diagnosed with Cervical Cancer
Martínez-Vega M, Rodríguez-Valencia A
Language: Spanish
References: 6
Page: 130132
PDF size: 127.80 Kb.
Text Extraction
No abstract.
REFERENCES
Flint M, Yi F, Saleh M, Liu X, Blank SV, LiuY. Cervical cancer in women under age 40: Acohort study of clinicopathological characteristicsand fertility-sparing surgery outcomes.Gynecol Oncol Rep. 2025;49:101224.
. International Agency for Research on Cancer.Global Cancer Observatory: Mexico factsheet – GLOBOCAN 2022 [Internet]. [Citado2025 Ago 31]. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/populations/484-mexico-fact-sheet.pdf
Tewari KS. Cervical cancer. N Engl J Med.2025;392(1):56–71.
Wirtz C, Mohamed Y, Engel D, Sidibe A,Holloway M, Bloem P, et al. Integrating HPVvaccination programs with enhanced cervicalcancer screening and treatment: a systematicreview. Vaccine. 2022;40(Suppl A):A116–23.
Covens A, Huang HQ, Monk BJ, Kim YB,Kim MH, DiSilvestro P, et al. Evaluation ofefficacy and fertility after nonradical surgicaltherapy (extrafascial hysterectomy or conebiopsy, with pelvic lymphadenectomy) forstage IA1, IA2, and IB1 cervical cancer(GOG-0278). Gynecol Oncol. 2025;195:59–65.
Jorgensen K, Meernik C, Wu CF, MurphyCC, Baker VL, Jarmon P, et al. Disparities infertility-sparing treatment and use of assistedreproductive technology after a diagnosisof cervical, ovarian, or endometrial cancer.Obstet Gynecol. 2023;141(2):341–353.